Development of a new recombinant serum albumin-based radiopharmaceutical 99mTc and 68Ga-labelled radiopharmaceutical for lung SPECT/CT and PET/CT (Q3957989): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Removed claim: EU contribution (P835): 968,650.702 euro)
(‎Changed an Item: Fixing rounding issue)
Property / EU contribution
 
968,650.70 Euro
Amount968,650.70 Euro
UnitEuro
Property / EU contribution: 968,650.70 Euro / rank
 
Preferred rank
Property / EU contribution: 968,650.70 Euro / qualifier
 
exchange rate to Euro: 0.00276521 Euro
Amount0.00276521 Euro
UnitEuro
Property / EU contribution: 968,650.70 Euro / qualifier
 
point in time: 6 December 2021
Timestamp+2021-12-06T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 09:48, 15 December 2021

Project Q3957989 in Hungary
Language Label Description Also known as
English
Development of a new recombinant serum albumin-based radiopharmaceutical 99mTc and 68Ga-labelled radiopharmaceutical for lung SPECT/CT and PET/CT
Project Q3957989 in Hungary

    Statements

    0 references
    0 references
    350,299,146 forint
    0 references
    968,650.70 Euro
    0.00276521 Euro
    6 December 2021
    0 references
    47.462349 percent
    0 references
    2 January 2018
    0 references
    31 December 2019
    0 references
    MEDI-RADIOPHARMA Egésszségügyi Szervező, Tanácsadó, Szolgáltató és Kereskedelmi Korlátolt Felelősségű Társaság
    0 references
    0 references

    47°22'38.10"N, 18°55'16.97"E
    0 references
    Érd, Pest
    0 references

    Identifiers

    VEKOP-2.1.1-15-2016-00082
    0 references